ABPI response to Lord O'Shaughnessy review


20 February 2023 - The Office for Life Sciences has today announced that Lord James O’Shaughnessy will conduct a review of the UK's commercial clinical trials landscape.

The review will offer recommendations on how commercial clinical trials can help the life sciences sector unlock UK growth and investment opportunities and advise on how to resolve key challenges in conducting commercial clinical trials in the UK.

Read ABPI statement

Michael Wonder

Posted by:

Michael Wonder